314 related articles for article (PubMed ID: 26676067)
1. Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment.
Drescher C; Konishi M; Ebner N; Springer J
J Cachexia Sarcopenia Muscle; 2015 Dec; 6(4):303-11. PubMed ID: 26676067
[TBL] [Abstract][Full Text] [Related]
2. Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment.
Drescher C; Konishi M; Ebner N; Springer J
Int J Cardiol; 2016 Jan; 202():766-72. PubMed ID: 26474466
[TBL] [Abstract][Full Text] [Related]
3. The wasting continuum in heart failure: from sarcopenia to cachexia.
von Haehling S
Proc Nutr Soc; 2015 Nov; 74(4):367-77. PubMed ID: 26264581
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle wasting after a severe burn is a consequence of cachexia and sarcopenia.
Song J; Clark A; Wade CE; Wolf SE
JPEN J Parenter Enteral Nutr; 2021 Nov; 45(8):1627-1633. PubMed ID: 34296448
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic options for cachexia and sarcopenia.
Molfino A; Amabile MI; Rossi Fanelli F; Muscaritoli M
Expert Opin Biol Ther; 2016 Oct; 16(10):1239-44. PubMed ID: 27382931
[TBL] [Abstract][Full Text] [Related]
6. Cachexia and sarcopenia: mechanisms and potential targets for intervention.
Argilés JM; Busquets S; Stemmler B; López-Soriano FJ
Curr Opin Pharmacol; 2015 Jun; 22():100-6. PubMed ID: 25974750
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.
Bowen TS; Schuler G; Adams V
J Cachexia Sarcopenia Muscle; 2015 Sep; 6(3):197-207. PubMed ID: 26401465
[TBL] [Abstract][Full Text] [Related]
8. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.
Ebner N; Elsner S; Springer J; von Haehling S
Curr Opin Support Palliat Care; 2014 Mar; 8(1):15-24. PubMed ID: 24452279
[TBL] [Abstract][Full Text] [Related]
10. Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions.
Stalmach A; Boehm I; Fernandes M; Rutter A; Skipworth RJE; Husi H
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080280
[TBL] [Abstract][Full Text] [Related]
11. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".
Muscaritoli M; Anker SD; Argilés J; Aversa Z; Bauer JM; Biolo G; Boirie Y; Bosaeus I; Cederholm T; Costelli P; Fearon KC; Laviano A; Maggio M; Rossi Fanelli F; Schneider SM; Schols A; Sieber CC
Clin Nutr; 2010 Apr; 29(2):154-9. PubMed ID: 20060626
[TBL] [Abstract][Full Text] [Related]
12. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.
Anker MS; von Haehling S; Springer J; Banach M; Anker SD
Int J Cardiol; 2013 Jan; 162(2):73-6. PubMed ID: 23174169
[TBL] [Abstract][Full Text] [Related]
13. Muscle wasting: an overview of recent developments in basic research.
Palus S; von Haehling S; Springer J
J Cachexia Sarcopenia Muscle; 2014 Sep; 5(3):193-8. PubMed ID: 25163459
[TBL] [Abstract][Full Text] [Related]
14. The complexity of treating wasting in ambulatory rehabilitation: Is it starvation, sarcopenia, cachexia or a combination of these conditions?
Yaxley A; Miller MD; Fraser RJ; Cobiac L; Crotty M
Asia Pac J Clin Nutr; 2012; 21(3):386-93. PubMed ID: 22705428
[TBL] [Abstract][Full Text] [Related]
15. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
[TBL] [Abstract][Full Text] [Related]
16. [Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].
Argilés JM; Busquets S; López-Soriano FJ; Figueras M
Nutr Hosp; 2006 May; 21 Suppl 3():38-45. PubMed ID: 16768029
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
[TBL] [Abstract][Full Text] [Related]
18. Cachexia versus sarcopenia.
Rolland Y; Abellan van Kan G; Gillette-Guyonnet S; Vellas B
Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):15-21. PubMed ID: 21076295
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the biology and therapy of muscle wasting.
Glass D; Roubenoff R
Ann N Y Acad Sci; 2010 Nov; 1211():25-36. PubMed ID: 21062293
[TBL] [Abstract][Full Text] [Related]
20. Muscle wasting in heart failure: An overview.
von Haehling S; Steinbeck L; Doehner W; Springer J; Anker SD
Int J Biochem Cell Biol; 2013 Oct; 45(10):2257-65. PubMed ID: 23665153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
